Lexicon Pharmaceuticals (LXRX) Fails to deliver data

Key failure to deliver metrics for Lexicon Pharmaceuticals :

• Last SEC data release: 2025-11-28
• Last 15 days FTD volume: £0.06 M
• Last 3 months FTD volume: £0.63 M
• Last 12 months FTD volume: £12.04 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Lexicon Pharmaceuticals (LXRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Lexicon Pharmaceuticals (LXRX) - since 2015

Lexicon Pharmaceuticals (LXRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Eterna Therapeutics ERNA	N/A	£2.03 M	🇺🇸 USA
Regeneron Pharmaceuticals REGN	£4.48 M	£71.05 M	🇺🇸 USA
Ultragenyx Pharmaceutical RARE	£1.09 M	£6.98 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	£2.28 M	£10.82 M	🇺🇸 USA
Thermo Fisher Scientific TMO	£25.71 M	£73.49 M	🇺🇸 USA
Esperion Therapeutics ESPR	£4.91 M	£11.36 M	🇺🇸 USA
Illumina ILMN	£6.08 M	£26.61 M	🇺🇸 USA
Ligand Pharmaceuticals LGND	£2.36 M	£8.91 M	🇺🇸 USA
Aerie Pharmaceuticals AERI	N/A	£0.94 M	🇺🇸 USA